ANDA 74550, held by Accord Hlthcare. Glipizide.
As of Nov 16, 2026, ANDA 74550 (Glipizide), held by Accord Hlthcare, was first approved by FDA on Sep 11, 1997, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 11, 1997 | Original application | Approved | None posted |
| Mar 22, 2017 | Supplement 11Labeling · Standard review | Approved | None posted |
| Aug 10, 2015 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jul 28, 2011 | Supplement 8Labeling | Approved | None posted |
| Nov 18, 2010 | Supplement 6Labeling | Approved | None posted |
| May 8, 2002 | Supplement 5Manufacturing | Approved | None posted |
| May 8, 2002 | Supplement 4Manufacturing | Approved | None posted |
| Aug 15, 2001 | Supplement 3Manufacturing | Approved | None posted |
| Jan 28, 2000 | Supplement 2Manufacturing | Approved | None posted |
| Jul 7, 1999 | Supplement 1Manufacturing | Approved | None posted |
| Sep 11, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters